USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 168 filers reported holding USANA HEALTH SCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $53,345,334 | +89881.2% | 1,179,163 | -3.5% | 0.09% | -3.2% |
Q1 2024 | $59,285 | -7.7% | 1,222,363 | +2.0% | 0.09% | -6.1% |
Q4 2023 | $64,250 | -9.3% | 1,198,697 | -0.8% | 0.10% | -18.2% |
Q3 2023 | $70,801 | -7.1% | 1,207,997 | -0.1% | 0.12% | +10.0% |
Q2 2023 | $76,234 | +0.0% | 1,209,297 | -0.2% | 0.11% | +8.9% |
Q1 2023 | $76,222 | +17.0% | 1,211,797 | -1.1% | 0.10% | +13.5% |
Q4 2022 | $65,170 | -99.9% | 1,224,997 | -6.3% | 0.09% | -14.4% |
Q3 2022 | $73,302,000 | -29.2% | 1,307,797 | -8.7% | 0.10% | -15.4% |
Q2 2022 | $103,605,000 | -8.4% | 1,431,797 | +0.5% | 0.12% | -7.5% |
Q1 2022 | $113,158,000 | -23.2% | 1,424,263 | -2.2% | 0.13% | -27.3% |
Q4 2021 | $147,357,000 | +5.2% | 1,456,097 | -4.1% | 0.18% | +1.1% |
Q3 2021 | $140,024,000 | -11.5% | 1,518,700 | -1.7% | 0.18% | -8.6% |
Q2 2021 | $158,295,000 | +3.4% | 1,545,400 | -1.4% | 0.20% | +4.2% |
Q1 2021 | $153,037,000 | +15.2% | 1,568,000 | -9.0% | 0.19% | +31.9% |
Q4 2020 | $132,841,000 | +0.5% | 1,722,966 | -4.0% | 0.14% | +9.1% |
Q3 2020 | $132,192,000 | +1.8% | 1,794,866 | +1.5% | 0.13% | +17.9% |
Q2 2020 | $129,873,000 | +42.2% | 1,768,666 | +11.8% | 0.11% | +25.8% |
Q1 2020 | $91,359,000 | -28.5% | 1,581,700 | -2.7% | 0.09% | -9.2% |
Q4 2019 | $127,714,000 | +12.6% | 1,625,900 | -2.0% | 0.10% | +2.1% |
Q3 2019 | $113,466,000 | -20.1% | 1,659,100 | -7.2% | 0.10% | -23.2% |
Q2 2019 | $142,053,000 | -11.2% | 1,788,400 | -6.2% | 0.12% | -13.8% |
Q1 2019 | $159,971,000 | -27.8% | 1,907,366 | +1.4% | 0.14% | -40.3% |
Q4 2018 | $221,529,000 | -12.5% | 1,881,674 | -10.4% | 0.24% | -6.5% |
Q3 2018 | $253,054,000 | -38.5% | 2,099,166 | -48.4% | 0.26% | +15.6% |
Q2 2018 | $411,250,000 | +144.1% | 4,066,932 | +107.3% | 0.22% | +22.3% |
Q1 2018 | $168,490,000 | +17.8% | 1,961,466 | +1.6% | 0.18% | +16.5% |
Q4 2017 | $142,988,000 | +29.2% | 1,930,966 | +0.7% | 0.16% | +21.5% |
Q3 2017 | $110,684,000 | -11.4% | 1,918,266 | -1.5% | 0.13% | -18.2% |
Q2 2017 | $124,884,000 | +23.1% | 1,948,266 | +10.6% | 0.16% | +12.0% |
Q1 2017 | $101,472,000 | +1.5% | 1,761,666 | +7.9% | 0.14% | -10.1% |
Q4 2016 | $99,933,000 | -9.7% | 1,632,900 | +104.2% | 0.16% | -19.4% |
Q3 2016 | $110,622,000 | +26.5% | 799,583 | +1.9% | 0.20% | +18.1% |
Q2 2016 | $87,460,000 | -0.9% | 784,883 | +7.9% | 0.17% | -1.2% |
Q1 2016 | $88,297,000 | -10.7% | 727,200 | -6.1% | 0.17% | -22.2% |
Q4 2015 | $98,902,000 | -11.8% | 774,183 | -7.5% | 0.22% | -19.4% |
Q3 2015 | $112,167,000 | +7.3% | 836,883 | +9.4% | 0.27% | +12.6% |
Q2 2015 | $104,515,000 | +14.5% | 764,783 | -6.9% | 0.24% | +22.7% |
Q1 2015 | $91,294,000 | +11.5% | 821,583 | +3.0% | 0.19% | -2.0% |
Q4 2014 | $81,855,000 | +58.7% | 797,883 | +13.9% | 0.20% | +40.4% |
Q3 2014 | $51,591,000 | -2.3% | 700,400 | +3.6% | 0.14% | +14.6% |
Q2 2014 | $52,815,000 | +7.1% | 675,900 | +3.3% | 0.12% | +4.2% |
Q1 2014 | $49,309,000 | +12.3% | 654,483 | +12.6% | 0.12% | +12.4% |
Q4 2013 | $43,927,000 | -0.8% | 581,200 | +13.9% | 0.10% | -1.9% |
Q3 2013 | $44,272,000 | +42.3% | 510,100 | +18.7% | 0.11% | +30.5% |
Q2 2013 | $31,109,000 | – | 429,800 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |